Anti-TNF Therapy Is Emerging as the Primary Treatment Modality in Pediatric Inflammatory Bowel Disease von Niklinska-Schirtz, B Joanna, Kugathasan, Subra

Volltext

Use, Durability, and Risks for Discontinuation of Initial and Subsequent Biologics in a Large Pediatric‐Onset IBD Cohort von Kaplan, Jess L., Liu, Chunyan, King, Eileen C., Bass, Julie A., Patel, Ashish S., Tung, Jeanne, Chen, Shiran, Lissoos, Trevor, Candela, Ninfa, Saeed, Shehzad, Colletti, Richard B., Adler, Jeremy, Baron, Howard I., Cabrera, José M., Dorsey, Jill M., Dykes, Dana M.H., Ebach, Dawn R., Garin‐Laflam, Monica P., Gold, Benjamin D., Grunow, John, Higuchi, Leslie M., Jester, Traci W., Lapsia, Sameer P., Leibowitz, Ian, Linvlle, Tiffany M., Morhardt, Tina L., Moses, Jonathan, Moulton, Dedrick, Nasiri‐Blomgren, Shaida, Niklinska‐Schirtz, B. Joanna, Ogunmola, Nicholas A., Palomo, Pablo J., Park, K.T., Pashankar, Dinesh S., Pasternak, Brad A., Radano, Marcella C., Samson, Charles M., Sandberg, Kelly C., Schaefer, Marc E., Shashidhar, Harohalli, Steiner, Steven J., Sullivan, Jillian S., Tomer, Gitit, Verstraete, Sophia G.

Volltext